600079 ST人福醫藥
按盤價 
18.500 -0.040 (-0.216%) | 2026/06 - 中期 人民幣(K¥) | 與去年同期 比較 | 2025/12 人民幣(K¥) | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | ||
| 營業總收入 | 12,060,702 | -0.03% | 23,962,010 | 25,435,484 | 24,524,741 | 22,337,719 | |
| 減：營業總成本 | 10,131,290 | -1.61% | 20,643,687 | 22,665,868 | 21,417,059 | 19,851,775 | |
| 其中:營業成本 | 6,011,902 | -3.83% | 12,409,036 | 14,103,261 | 13,290,992 | 12,615,138 | |
| 財務費用 | 211,108 | 74.70% | 303,146 | 350,704 | 304,519 | 236,944 | |
| 資產減值損失 | (15,397) | -14.81% | (420,167) | (393,861) | (61,407) | (88,312) | |
| 公允價值變動收益 | (1,334) | -17.54% | 11,824 | 112,717 | 136,855 | 43,417 | |
| 投資收益 | 39,929 | -15.70% | 101,039 | 133,086 | 206,785 | 835,557 | |
| 其中：對聯營企業和合營企業的投資收益 | 41,098 | 0.92% | 106,613 | 68,161 | 59,992 | 22,514 | |
| 營業利潤 | 2,018,677 | 10.04% | 3,197,865 | 2,522,029 | 3,447,174 | 3,516,028 | |
| 利潤總額 | 1,996,380 | 11.58% | 3,056,461 | 2,422,830 | 3,383,829 | 3,426,053 | |
| 減：所得稅費用 | 304,816 | 4.37% | 564,005 | 644,487 | 568,563 | 354,751 | |
| 淨利潤 | 1,691,565 | 12.98% | 2,492,456 | 1,778,343 | 2,815,266 | 3,071,302 | |
| 減：非控股權益 | 362,011 | 5.69% | 637,122 | 448,598 | 680,781 | 587,194 | |
| 股東淨利潤 | 1,329,554 | 15.15% | 1,855,334 | 1,329,745 | 2,134,485 | 2,484,109 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.810 | 14.08% | 1.140 | 0.820 | 1.320 | 1.540 | |
| 每股派息 (元) * | -- | -- | 0.480 | 0.470 | 0.460 | 0.160 | |
| 每股淨資產 (元) * | 11.830 | 5.31% | 11.587 | 10.797 | 10.441 | 9.210 | |
| 審計意見 # | -- | 标准无保留意见 | 带有强调事项段、持续经营重大不确定性段落、其他信息段落中包含其他信息未更正重大错报说明的无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 15/09/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
